newsSildenafil should be avoided in valvular disease 29 August 2017 | By Dr Zara Kassam (European Pharmaceutical Review)The SIOVAC trial2 has tested the potential of sildenafil to improve long-term outcomes of patients with residual pulmonary hypertension...